BackNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Total Assets

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s total assets is $700M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$704.45M
13.58% YoYΔ $-110.66M vs prior year quarter

Peer average

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Total Assets History

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) vs. peers: Total Assets Comparison

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) FAQ

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) currently reports a total assets of $700M as of June 2026. That compares with $820M in the prior-year period — down 13.6% year over year. Use the charts on this page to explore NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s total assets history and peer comparisons.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s total assets decreased from $820M to $700M — a 13.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) reported $700M in total assets as of June 2026. That compares with $820M in the prior-year period — down 13.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $700M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV - Warrants (15/11/2027), and consider following NAMSW for alerts when major investors trade the stock.